Evidence map›Paper›PMID 34623629›Full record

ArticleJournal of nephrology2022

Neutrophil-to-lymphocyte ratio is a marker for acute kidney injury progression and mortality in critically ill populations: a population-based, multi-institutional study.

Jia-Jin Chen, George Kuo, Pei-Chun Fan, Tao-Han Lee, Chieh-Li Yen, Cheng-Chia Lee, Ya-Chung Tian, Chih-Hsiang Chang

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jia-Jin ChenDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
George KuoDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Pei-Chun FanDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Tao-Han LeeDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Chieh-Li YenDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Cheng-Chia LeeDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Ya-Chung TianDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Chih-Hsiang ChangDepartment of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan. franwisandsun@gmail.com.
Chang Gung Memorial Hospital · TWLinkou Chang Gung Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundsNeutrophil-to-lymphocyte ratio (NLR), a surrogate marker of systemic response to physiological stress, is used for prognosis prediction in many diseases. However, the usefulness of this marker for predicting acute kidney injury (AKI) progression is unclear.

methodsThis retrospective study was based on the Chang Gung Research Database. Patients admitted to the intensive care unit with a diagnosis of stage 1 or 2 AKI were identified. The primary outcome was a composite of progression to stage 3 AKI, requirement of renal replacement therapy, or 14-day in-hospital mortality. The association between NLR and the primary outcome was examined using a logistic regression model and multivariable analysis. The nonlinearity and cutoff points of this relationship were determined using a restricted cubic spline model.

resultsA total of 10,441 patients were enrolled. NLR level at the time of stage 1-2 AKI diagnosis was a marker of adverse outcomes. After adjustment for confounders, NLR was independently associated with the composite outcome of AKI progression, renal replacement therapy, or mortality. The restricted cubic spline model revealed a J-shaped curve, with the lowest odds ratio for an NLR between 7 and 38. Subgroup analysis revealed linear and J-shaped relationships between NLR and the primary outcome in patients admitted to the intensive care unit for medical reasons and for cardiovascular surgery, respectively.

conclusionsNLR is an independent marker of AKI progression and in-hospital mortality. Because it is readily available in daily practice, it might be used for risk stratification in the AKI population.

Indexed as

Acute Kidney InjuryNeutrophilsBiomarkersCritical IllnessHumansIntensive Care UnitsLymphocytesPrognosisRetrospective StudiesBiomarkersAKINLROutcomePrediction

Identifiers

PMID34623629
PMCPMC8498757
OpenAlexW3203058209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.